Madison is a physician-scientist and clinical development leader with approximately 18 years of experience leading global Phase I–III trials across oncology, immunology, and rare diseases within both CRO and biotech environments. She brings a rare combination of scientific depth and operational insight, ensuring that development strategies are both medically rigorous and execution-ready.

With extensive hands-on experience in medical monitoring, Madison remains closely engaged in trial conduct while simultaneously shaping overarching program strategy. She works in seamless partnership with clinical operations, biometrics, safety, and regulatory teams to deliver inspection-ready data packages and successful regulatory submissions across major global jurisdictions.

Throughout her career, she has partnered closely with emerging and mid-size biotech companies, helping them refine development plans, anticipate regulatory expectations, and strategically de-risk pivotal trials. Her ability to align scientific objectives with commercial and financing milestones enables sponsors to accelerate progress toward key value inflection points while maintaining the highest standards of patient safety and data integrity.

Recognized for her collaborative leadership style and pragmatic decision-making, she plays a central role in translating complex clinical science into clear, actionable development pathways that drive both regulatory and investor confidence.